Illumina Inc
NASDAQ:ILMN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Illumina Inc (ILMN) under the Base Case is 171.4 USD per share.
Compared with the current market price of 219.09 USD, the stock appears
Overvalued by 22% .
The intrinsic value is calculated using the DCF method. The model assumes Illumina's operating margin rises to 29% by 2033, above its best of 20% over the last six years. If its margin stayed at its five-year average of 7.7%, the estimate would be about $58.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Illumina Does
Illumina makes DNA sequencing systems and the consumables that run on them. Its machines read genetic code, and its test kits and reagents are used to prepare samples and generate sequencing data. The company mainly sells to hospitals, research labs, biotech companies, and clinical testing groups that need to analyze DNA for science or diagnosis.
- Headquarters
- United States of America US
- Employees
- 8 600
- IPO date
- Jun 28, 2000
Illumina has a narrow economic moat
Replacing Illumina equipment can mean rebuilding laboratory routines, retraining staff and checking that tests still produce reliable results, making a cheaper rival costly to adopt. Patents also prevent competitors from directly copying protected parts of its sequencing technology. These barriers help protect repeat purchases of supplies, rather than keeping competing systems out entirely.
Read the full moat analysis
Revenue & Expenses Breakdown
Illumina Inc
Earnings Waterfall
Illumina Inc
What is the Intrinsic Value of one ILMN stock?
The intrinsic value for Illumina Inc (ILMN) under the Base Case is 171.4 USD.
Is ILMN stock undervalued or overvalued?
Compared with the current market price of 219.09 USD, the stock appears Overvalued by 22% .
